Seer, Inc. Share Price & Technical Analysis
SEER · $1.79 (+1.13%)
Healthcare / Biotechnology
$1.79
+1.13%
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis s…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
-5% return in May, -2% avg return in past 3 year May month.
2% return in 2026, -21% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -5% | -6% | 0% | 18% | -5% | – | – | – | – | – | – | – | 2% |
| 25 | 4% | -9% | -19% | 18% | -5% | 5% | 0% | -5% | 10% | 0% | -14% | -5% | -19% |
| 24 | -11% | 6% | 6% | 11% | -14% | -6% | 18% | -15% | 18% | -5% | 32% | -8% | 30% |
| 23 | -22% | -9% | -5% | -13% | 12% | 16% | 19% | -48% | -15% | -27% | 0% | 19% | -74% |
| 22 | -31% | -4% | 2% | -53% | 24% | 0% | 0% | 15% | -22% | -1% | -19% | -12% | -101% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company also offers Proteograph ONE, a third-generation assay; Proteograph DIRECT, which provides an automated approach for direct digestion of samples for bottom-up LC-MS proteomic analysis; and Proteograph Analysis Suite, a data analytics software suite designed to support quality control, data management, and interpretation of Proteograph output which is currently offered as a cloud-based solution. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$100.22M
P/E ratio
—
52W high
$2.41
52W low
$1.65
Volume
5,59,403
Beta
1.64
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Seer, Inc. share price today?
- Seer, Inc. (SEER) last traded around $1.79 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does SEER have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for SEER. Download the app for real-time alerts.
- How can I analyze Seer, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.